Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $7.1100 (0.85%) ($7.1100 - $7.1100) on Thu. Feb. 11, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.84% (three month average) | RSI | 35 | Latest Price | $7.1100(0.85%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | AUTL declines -3% a day on average for past five trading days. | Weekly Trend | AUTL declines -4.6% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) SKYY(13%) XBI(13%) LIT(12%) ARKG(11%) BNDX(11%) | Factors Impacting AUTL price | AUTL will decline at least -2.42% in a week (0% probabilities). USO(-7%) TBT(-7%) IGOV(-7%) UNG(-5%) VIXM(-4%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.42% (StdDev 4.84%) | Hourly BBV | -0.2 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $8.12 | 5 Day Moving Average | $7.68(-7.42%) | 10 Day Moving Average | $7.65(-7.06%) | 20 Day Moving Average | $8.12(-12.44%) | To recent high | -40.2% | To recent low | 0.9% | Market Cap | $372m | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |